Health

Swiss drugmaker Roche announced that it has agreed to buy LumiraDx’s Point of Care diagnostics platform for about $295m. LumiraDx shares rose 20% to 76

A man may regain the use of his hand, which was paralysed after a serious car accident, thanks to a pioneering nerve transfer operation from

In May of this year the federal food and drug agency amended its guidelines to allow gay and bisexual men in monogamous relationships to donate

Iovance Biotherapeutics said Wednesday that the U.S. Food and Drug Administration has placed its trial of a therapy for a type of lung cancer on

Vaccine manufacturer COVID-19 BioNTech aims to start production at its mRNA vaccine factory in Rwanda in 2025, according to company officials, which will thus become

An Alabama woman with a rare birth defect that causes her to have two uteruses gave birth to healthy twin girls. Kelsey Hatcher and her

AstraZeneca announced on Tuesday that it will buy China’s Gracell Biotechnologies for $1.2 billion, bringing the British drugmaker’s ambitions in the field of cell therapies

Bayer has won a lawsuit brought by a California man who claimed he developed cancer from exposure to its Roundup herbicide, ending a streak of

Bristol Myers Squibb announced that it will buy RayzeBio for about $4.1 billion to bolster its cancer drug business, the second major deal the drugmaker

Bayer won a lawsuit filed by a California resident who claimed he developed cancer as a result of exposure to the herbicide Roundup, ending the